KELER TIBOR 4
4 · Celldex Therapeutics, Inc. · Filed Jun 21, 2021
Insider Transaction Report
Form 4
KELER TIBOR
Sr. VP & CSO
Transactions
- Award
Incentive Stock Option (right to buy)
2021-06-17+91,000→ 91,000 totalExercise: $28.00From: 2022-06-17Exp: 2031-06-17→ Common Stock (91,000 underlying)
Footnotes (2)
- [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
- [F2]25% vest on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.